Overview

Gabapentin Treatment of Cannabis Dependence

Status:
Completed
Trial end date:
2016-05-19
Target enrollment:
Participant gender:
Summary
This is a clinical study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.
Phase:
Phase 2
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Gabapentin
gamma-Aminobutyric Acid